Stanford University


Showing 1-100 of 142 Results

  • Mohammad Abbasi, PhD

    Mohammad Abbasi, PhD

    RSE / Data Scientist and Data Manager at Transitional AI lab, Psych/Public Mental Health & Population Sciences

    BioI am a Research Software Engineer (RSE) | Data Scientist & Data Manager at the Stanford Translational AI (STAI) Lab. I lead data engineering and AI infrastructure across large-scale neuroscience and healthcare projects, building standards-first, end-to-end pipelines for data collection, curation, preprocessing, and multimodal integration. My work emphasizes reproducibility, scalability, and interoperability through BIDS-style schemas, schema validation, containerized deployments, and CI/CD across heterogeneous computing environments.

    I have designed and maintained containerized preprocessing workflows for thousands of subjects across major datasets, automating modality-specific steps such as registration, intensity normalization, bias-field correction, motion/confound estimation, quality control, and downstream metadata exports. I ensure these pipelines are robust, well-documented, versioned, and reusable across projects, sites, and modalities.

  • Leslie Adams

    Leslie Adams

    Assistant Professor of Psychiatry and Behavioral Sciences (Public Mental Health) and, by courtesy, of Pediatrics

    BioLeslie Adams, PhD, MPH is an Assistant Professor in the Division of Public Mental Health and Population Sciences at Stanford University School of Medicine, where she focuses on addressing mental health disparities among people of African descent and marginalized communities. As a behavioral scientist, her research emphasizes the role of structural racism, gender norms, and psychosocial stressors in influencing mental health outcomes. Dr. Adams employs mixed-methods approaches, including ecological momentary assessment and passive data sensing, to explore real-time stressors like racial discrimination and their link to depressive symptoms and suicidality. Prior to her role at Stanford, she served as an Assistant Professor at Johns Hopkins Bloomberg School of Public Health and was a David E. Bell Postdoctoral Fellow at the Harvard Center for Population and Development Studies.

  • Ehsan Adeli

    Ehsan Adeli

    Assistant Professor (Research) of Psychiatry and Behavioral Sciences (Public Mental Health and Populations Sciences) and, by courtesy, of Computer Science and of Biomedical Data Science

    Current Research and Scholarly InterestsMy research lies in the intersection of Machine Learning, Computer Vision, Healthcare, Ambient Intelligence, and Computational Neuroscience.

  • Steven Adelsheim

    Steven Adelsheim

    Clinical Professor, Psychiatry and Behavioral Sciences

    BioSteven Adelsheim, MD is a child and adolescent psychiatrist and Associate Chair for
    Community Engagement in Stanford’s Department of Psychiatry, where he directs the Center for
    Youth Mental Health and Wellbeing. A national leader in early intervention, Dr. Adelsheim
    spearheaded the launch of allcove—a youth-driven, integrated mental health model now
    expanding across California. He also co-leads PEPPNET, the national early psychosis clinical
    network. His work extends to youth suicide prevention, school mental health systems, and
    partnerships with Indigenous communities to strengthen culturally grounded early intervention
    for tribal youth. Dr. Adelsheim’s career is grounded in building equitable, accessible mental
    health systems for young people nationwide.

  • Rania Awaad, MD

    Rania Awaad, MD

    Clinical Professor, Psychiatry and Behavioral Sciences

    Current Research and Scholarly InterestsAs the Director of the Muslims and Mental Health Lab, Dr. Awaad is dedicated to creating an academic home for the study of mental health as it relates to the Islamic faith and Muslim populations. The lab aims to provide the intellectual resources to clinicians, researchers, trainees, educators, community and religious leaders working with or studying Muslims.

  • Daniel Michael Blonigen

    Daniel Michael Blonigen

    Associate Professor of Psychiatry and Behavioral Sciences (Public Mental Health and Population Sciences)

    BioDr. Blonigen is a Research Career Scientist and an Associate Director at the Center for Innovation to Implementation (Ci2i), VA Palo Alto Health Care System. He is also an Affiliate Investigator with the VA National Center for Homelessness Among Veterans, and an Associate Professor in the Department of Psychiatry and Behavioral Sciences, Stanford University School of Medicine. He received his doctorate in clinical psychology from the University of Minnesota and is a former VA Career Development Awardee. He is licensed as a clinical psychologist in the State of California.

    Dr. Blonigen’s research mission is to identify and develop innovations to increase access and engagement in substance use and mental health care for vulnerable populations. In particular, he is interested in testing the effectiveness and implementation potential of mobile health and peer-based interventions for justice-involved and homeless veterans. He is currently leading or co-leading multisite trials of behavioral interventions for justice-involved and homeless veterans. He is also funded by VA Health Systems Research to tailor smartphone applications for self-management of unhealthy drinking for veteran primary care patients and use of peer specialists to increase patient engagement with these apps.

    In addition to research, Dr. Blonigen is actively involved in mentoring and teaching VA research fellows and Stanford University residents. These roles include serving as a faculty mentor for the Stanford Forensic Psychiatry Fellowship Program and the Ci2i VA Palo Alto Training Program. He is a member of several VA management and oversight committees and has served as a grant reviewer for national and international funders. He is an invited speaker at national conferences and cyberseminars devoted to substance use and mental health research, and he holds editorial positions for leading addiction, personality, and assessment journals.

  • Jessica Yelena Breland

    Jessica Yelena Breland

    Clinical Associate Professor (Affiliated), Psych/General Psychiatry and Psychology (Adult)
    Staff, Psych/Public Mental Health & Population Sciences

    BioJessica Breland, MS, PhD is a licensed psychologist and a Core Investigator at the Center for Innovation to Implementation in the VA Palo Alto Health Care System. Dr. Breland received her PhD in psychology from Rutgers and completed her clinical internship at the Baylor College of Medicine in Houston, TX.

    Her work focuses on using quantitative and qualitative methods to: 1) assess outcomes related to the implementation of evidenced-based treatments, especially through controlled trials in novel settings (e.g., primary care) or with novel methods (e.g., apps); 2) identify and reduce racial and ethnic disparities in health; and 3) enhance care for patients with chronic conditions, such as obesity or diabetes.

  • Christiane Brems, PhD, ABPP, ERYT500, C-IAYT

    Christiane Brems, PhD, ABPP, ERYT500, C-IAYT

    Clinical Professor, Psychiatry and Behavioral Sciences

    BioChristiane Brems, PhD, ABPP, RYT-500, C-IAYT, is the Founding Director of YogaX, a Special Initiative in the Department of Psychiatry and Behavioral Science. She received her PhD in Clinical Psychology from Oklahoma State University in 1987. Dr. Brems is licensed as a psychologist in several US states and board-certified as a clinical psychologist by the American Board of Professional Psychology (ABPP). She is a registered yoga teacher (E-RYT500) and certified C-IAYT yoga therapist. She is also certified in Interactive Guided Imagery.

    She began her career in academia at the University of Oklahoma Health Sciences Center. She then served on faculty at the University of Alaska Anchorage for 23 years, where she held a variety of leadership positions, including as (Co-Founding) Director of the Center for Behavioral Health Research and Services, (Co-Founding) Director of the PhD Program in Clinical-Community Psychology, and Interim Vice Provost for Research and Dean of the Graduate School. Most recently, she served for nearly six years as Dean and Professor of the School of Graduate Psychology (SGP) at Pacific University Oregon.

    Dr. Brems has worked for decades as an applied researcher and clinical practitioner with particular interests in health promotion, rural healthcare delivery, and all things yoga. Her work has been funded by grants and contracts from the National Institutes of Health, the Centers for Disease Control and Prevention, the Substance Abuse and Mental Health Service Administration, and local and State of Alaska funding sources. She has shared her work extensively in over 120 peer-reviewed journal articles, 100s of technical reports, and several books, including the Comprehensive Guide to Child Psychotherapy (now in its 4th edition), Dealing with Challenges in Psychotherapy and Counseling, Basic Skills in Counseling and Psychotherapy, and others. Dr. Brems is committed to excellence in and integration of clinical services, teaching, consultation, and research.

    Dr. Brems has integrated yoga, mindfulness, complementary interventions, and self-care strategies in her work as a consultant, author, dean, teacher, researcher, mentor, supervisor, colleague, and service provider. She values these practices as crucial aspects of day-to-day professional and personal life and seeks to enhance access to them for all who can benefit.

  • Eve Carlson

    Eve Carlson

    Clinical Professor, Psychiatry and Behavioral Sciences

    BioEve Carlson is a Clinical Professor who focuses on fostering mental health after traumatic stress. She is a clinical psychologist and a researcher with the National Center for Posttraumatic Stress Disorder’s Dissemination and Training Division. Her primary interests are in measurement development and recovery after traumatic stress. She collaborates with faculty in Surgery (David Spain) and Medicine (Lisa Shieh) to study mental health of patients hospitalized after sudden, severe illness or injury, ethnoracial disparities in traumatic stress risks and responses, screening for risk of mental health problems, and preventive mental health care. Our research has found disparities in mental health responses in patients hospitalized after emergency care across ethnoracial groups that are explained by variance in risk factors, including social determinants of health. As PIs of a multi-center study funded by the National Institute on Minority Health and Health Disparities, Dr. Carlson and Dr. Spain and their collaborators have developed and validated a mental health risk screen for patients hospitalized after emergency care for acute illness or injury. Data from patients who identify as Asian American/Pacific Islander, Black, Latinx, multirace, and White were analyzed to inform screen development, and the screen accurately predicts later mental health outcomes within these ethnoracial groups. The Hospital Mental Health Risk Screen can be administered to patients hospitalized after emergency care to assess their risk for later mental health problems. Patients screening positive for mental health risk can be given preventive mental health care. Dr. Carlson has collaborated with Dr. Josef Ruzek and Dr. Matthew Cordova to create the TLC by recently admitted hospital patients reduces later mental health symptoms.

  • Steven Chan, MD MBA

    Steven Chan, MD MBA

    Clinical Associate Professor (Affiliated), Psych/Public Mental Health & Population Sciences
    Staff, Psychiatry and Behavioral Sciences

    BioDr. Steven Chan is a Faculty Co-Director at Stanford Frontier Technology Lab, a member of Stanford Psychiatry’s TechHub Leadership Committee, faculty with the Stanford Addiction Medicine Fellowship, and a clinical educator caring for patients with substance use disorders (SUD) and addictions.

    Dr. Chan is a clinical informaticist, addiction medicine physician, and psychiatrist. He is a clinical associate professor affiliated with the Stanford University School of Medicine, and Immediate Past Chair of the Committee on Innovation at the American Psychiatric Association. Dr. Chan is a sought-after national speaker whose ideas, thoughts, and research have been featured at Google headquarters, JAMA, Telemedicine and e-Health, JMIR (Journal of Medical Internet Research), Wired, PBS, and NPR Ideastream. He serves as Chief Technology Officer and co-founder of AsyncHealth — a University of California-backed digital mental health startup supported by Berkeley SkyDeck PAD-13 and the National Science Foundation's Innovation Corps (NSF i-Corps) — and writes at both @stevenchanMD and @mpowerhacks.

  • Hannah Cheng

    Hannah Cheng

    Soc Science Rsch Asst 3, Psych/Public Mental Health & Population Sciences

    BioHannah Cheng, MS is a Research Scientist at the Stanford Center for Dissemination and Implementation. Her overarching goal is to leverage implementation science to dismantle systemic barriers and improve access to behavioral health services. Her work focuses on identifying strategies to implement innovations in resource-limited settings and integrating economic evaluations in implementation research to maximize return on investment

  • Helene Chokron Garneau

    Helene Chokron Garneau

    Sr Research Scholar, Psych/Public Mental Health & Population Sciences

    Current Role at StanfordSenior Research Scientist
    Co-Director, Center for Dissemination and Implementation At Stanford (C-DIAS)

  • Timothy Durazzo

    Timothy Durazzo

    Professor of Psychiatry and Behavioral Sciences (Public Mental Health and Population Sciences)

    Current Research and Scholarly InterestsThe mission of the Durazzo BRASS lab is to better understand how the interplay between biomedical, psychological and social factors influence treatment outcome in Veterans and civilians seeking treatment for alcohol and substance use disorders. To accomplish this mission, our multidisciplinary team integrates information from advanced neuroimaging, neurocognitive assessment, psychodiagnostic and genotyping methods to identify the biopsychosocial factors associated with relapse and sustained sobriety. Data from Veteran's Administration and Stanford funded Clinical trials are currently being analyzed by the BRASS lab to evaluate the efficacy of repetitive transcranial magnetic stimulation techniques as novel complementary treatments to reduce the high rate of return to hazardous drinking experienced by individuals with alcohol and substance abuse disorders. The ultimate goal of our multidisciplinary research program is to promote the development of more effective biomedical and behavioral treatments for alcohol and substance use disorders through consideration of the brain biology, psychology and social circumstances of each individual.

  • David Eagleman

    David Eagleman

    Adjunct Professor, Psych/Public Mental Health & Population Sciences

    BioDavid Eagleman is a neuroscientist, bestselling author, and Guggenheim Fellow. Dr. Eagleman’s areas of research include sensory substitution, time perception, vision, and synesthesia. He also studies the intersection of neuroscience with the legal system, and in that capacity he directs the non-profit Center for Science and Law. Eagleman is the writer and presenter of The Brain, an Emmy-nominated television series on PBS and BBC. He is the author of 8 books, including Livewired, The Runaway Species, The Brain, Incognito, and Wednesday is Indigo Blue. He is also the author of a widely adopted textbook on cognitive neuroscience, Brain and Behavior. His internationally bestselling book of literary fiction, SUM, has been translated into 32 languages, turned into two operas, and named a Best Book of the Year by Barnes and Noble. Dr. Eagleman has been a TED speaker, a guest on the Colbert Report, and profiled in the New Yorker magazine. He has launched several neuroscience companies from his research, including Neosensory and BrainCheck.

  • William O Faustman

    William O Faustman

    Clinical Professor (Affiliated), Psych/Public Mental Health & Population Sciences
    Staff, Psychiatry and Behavioral Sciences

    BioDr. Faustman received his doctorate in clinical psychology from the University of Mississippi and completed his internship at the VA Palo Alto Health Care System. He has an active interest in training, administration, forensic practice, and clinical care in inpatient psychiatry. His research interests have focused on severe mental illness with an emphasis in areas such as cognition and clinical assessment.. He serves as a member of the Stanford IRB and coordinates the American Psychological Association accredited postdoctoral fellowship program at the VA Palo Alto. He holds Chartered Psychologist status with the British Psychological Society,

  • Howard H Fenn MD

    Howard H Fenn MD

    Adjunct Clinical Associate Professor, Psychiatry and Behavioral Sciences

    BioCurrent CV available on request to
    hhfenn@aol.com

    CLINICAL:
    Inpatient psychiatry attending at VA HCS Palo Alto for over 30 years.
    Medical Director, Geriatric Psychiatry unit, VA HCSC Palo Alto/Menlo Park for 10 years
    Outpatient psychiatrist at Palo Alto Medical foundation/Sutter for 15 years

    CURRENT PUBLICATIONS:
    Lead Editor, Inpatient Geriatric Psychiatry, Springer, 2019

    LEGAL/FORENSIC:
    Consultation practice on legal issues and court testimony for >40 years
    Expert consultant/witness for Coleman vs. California Department of Corrections for 4 years
    Qualified Medical Examiner (QME) for Division of Worker's Compensation for 15 years
    Compensation and Pension Unit, VA HCS Palo Alto for 5 years

    SEMINAR LEADER:
    Psychiatric Issues in Cognitive Impairment -- Stanford/VA Alzheimer's Center (SVAAC)
    Legal Aspects of Geriatric Psychiatry (Stanford/VA Geriatric Psychiatry Fellowship
    Didactic topics on inpatient psychiatry rotation for Stanford Geriatric Psychiatry fellows

    EDUCATIONAL/ADMINISTRATIVE:
    Program Director, Stanford/VA Geriatric Psychiatry Fellowship, 3 years
    Site Director, Inpatient Psychiatry Rotation/Geriatric Medicine Fellowship --6 years

    SCHOLARSHIP:
    Lead Editor of textbook, Inpatient Geriatric Psychiatry, published by Springer in 2019.
    Slide presentations published by the American Society of Clinical Pharmacology (ASCP), editor Ira Glick, MD, entitled:
    --Pharmacological Treatment of PTSD
    --Behavioral and Psychological symptoms of Dementia
    Chapters, review articles on topics of Medication management for Major Neurocognitive Disorder with Behavioral Disturbance
    Chapter in Inpatient Geriatric Psychiatry, in On-Call Geriatric Psychiatry (2016), Springer.
    .

  • Nico Fischer

    Nico Fischer

    Affiliate, Psych/Public Mental Health & Population Sciences

    Bio2022-2026 Santa Clara High School
    Advisor, Stanford Center for Youth Mental Health and Wellbeing
    Chair, County of Santa Clara Youth Task Force

  • Becky Fullmer

    Becky Fullmer

    Administrative Associate 3, Psych/Public Mental Health & Population Sciences

    Current Role at StanfordBecky provides administrative support to Dr. Carolyn Rodriguez and the OCD Research Lab within the School of Medicine's Psychiatry and Behavioral Sciences Department.

  • Ansgar Furst

    Ansgar Furst

    Clinical Associate Professor (Affiliated), Psych/Public Mental Health & Population Sciences
    Staff, Psychiatry and Behavioral Sciences

    BioDr. Furst is a Clinical Associate Professor (affiliated) of Psychiatry and Behavioral Sciences and of Neurology and Neurological Sciences at Stanford University School of Medicine. He is a Principal Investigator and Director of the California War Related Illness and Injury Study Center (WRIISC) Advanced Fellowship Post-Doctoral program and Associate Director of Neuroimaging. He is also a Senior Research Scientist at the Polytrauma System of Care (PSC) at VA Palo Alto Health Care System. Dr. Furst serves as Associate Editor for the journal Frontiers in Neurology and is a member of the editorial board of NEUROLOGY. His research focuses on chronic multisymptom illness, traumatic brain injury, sleep, pain and neurodegenerative diseases.

    For more information please visit:
    https://med.stanford.edu/furstlab.html

    Member of:
    Center for Sleep and Circadian Sciences
    https://med.stanford.edu/cscs.html

    Faculty Affiliate:
    Wu Tsai Human Performance Alliance
    https://humanperformance.stanford.edu

  • Jessica E. Gonzalez

    Jessica E. Gonzalez

    Soc Science Rsch Asst 3, Psych/Public Mental Health & Population Sciences

    BioJessica E. Gonzalez, MSW is the Associate Director for the Mental Health Technology Transfer Center (MHTTC) Network Coordinating Office (NCO). The MHTTC NCO is part of the Center for Dissemination and Implementation (CDI) in the Department of Psychiatry and Behavioral Sciences at Stanford University School of Medicine. Through the MHTTC School Mental Health Initiative, Jessica is coordinating the work of 12 centers that provide training and technical assistance to the mental health and school mental health workforce to increase the use of evidence-based mental health prevention, treatment, and recovery support services for students across the United States.

    Jessica has worked in the community as a social worker providing mental health services in school and outpatient clinic settings to children and adolescents of diverse socioeconomic, cultural and ethnic backgrounds. In addition, she has over 10 years of experience in project management and coordination for research and evaluation in the areas of early childhood learning and development, special education, post-secondary education attainment, and delivery of school mental health services. Jessica has also worked for several high school and college programs in the area seeking to improve educational outcomes for first-generation and low-income students of color.

  • Cheryl Gore-Felton, Ph.D.

    Cheryl Gore-Felton, Ph.D.

    Walter E. Nichols, MD Professor in the School of Medicine

    Current Research and Scholarly InterestsMy clinical focus is the treatment of anxiety disorders, including post traumatic stress disorder. My research focuses on developing effective psychotherapy interventions to reduce chronic stress as well as enhance positive health behaviors to reduce morbidity and mortality among patients coping with chronic, medical illnesses which are often life threatening.

  • Heather Gotham

    Heather Gotham

    Clinical Professor, Psychiatry and Behavioral Sciences

    Current Research and Scholarly InterestsDr. Gotham’s research focuses on implementation science, including factors affecting implementation, and training and education of health care providers, across a range of evidence-based practices for adolescent and adult substance use and mental health disorders, co-occurring mental health and substance use disorders, and screening, brief intervention, and referral to treatment (SBIRT).

  • J. Christian Greer

    J. Christian Greer

    Lecturer, Psychiatry and Behavioral Sciences

    BioJ. Christian Greer, PhD, is a scholar of Religious Studies with a special focus on psychedelic culture. He holds a MDiv from Harvard Divinity School, as well as a MA and PhD (cum laude) in Western Esotericism from the University of Amsterdam. While a postdoctoral researcher at Harvard Divinity School, he led a series of seminars on global psychedelic cultures, which culminated in the creation of the "Harvard Psychedelic Walking Tour," a free audio guide detailing how the Harvard community has shaped the modern history of psychedelic culture. He is also the co-founder, and currently the co-chair of the "Drugs and Religion" program unit at the American Academy of Religion.

    His forthcoming book, "Angelheaded Hipsters: Psychedelic Militancy in Nineteen Eighties North America" (Oxford University Press), explores the expansion of psychedelic culture within fanzine networks in the late Cold War era. He has held teaching positions at Harvard University and Yale University, and is currently a lecturer at Stanford University. His other books include, "Void Machines: the Paper Shrines of J. Christian Greer," a collection of his esoteric artworks, and "Kumano Kodo: Pilgrimage to Powerspots" (co-authored with Dr. Michelle Oing) which analyzes the pilgrimage folklore associated with the rainforests of Japan's Kii Peninsula.

    Each winter, he partners with the University of Amsterdam to offer an introduction to the study of occultism, hosted on ZOOM, entitled "FORBIDDEN KNOWLEDGE: Introduction to Esotericism." Similarly, each summer, he organizes an intensive summer school course on the University of Amsterdam's campus entitled, "THE PSYCHEDELIC UNIVERSE: Global Perspectives on Higher Consciousness."

  • Kritee Gujral

    Kritee Gujral

    Instructor (Affiliated), Psych/Public Mental Health & Population Sciences

    Current Role at Stanford- Instructor (Affiliated), Stanford Department of Psychiatry and Behavioral Sciences
    - Research Scientist, Stanford Center for Responsible and Effective AI Technology Enhancement (CREATE)
    - Researcher & Data Analyst, Stanford-Surgery Policy Improvement Research & Education Center (S-SPIRE)

  • Laura Michele Hack

    Laura Michele Hack

    Assistant Professor of Psychiatry and Behavioral Sciences (Public Mental Health and Population Sciences)

    BioDr. Laura M. Hack is an Assistant of Psychiatry and Behavioral Sciences at Stanford University and the Veterans Affairs Palo Alto Health Care System (PAVAHCS). As Associate Director of the Novel & Precision Neurotherapeutics Program at the Stanford Center for Precision Mental Health, Dr. Hack leads a translational, patient-centered research group that designs and implements mechanistic clinical trials for biologically informed subtypes of Mood, Anxiety, and Trauma-related Disorders (MATRDs).

    Her work spans repurposed pharmacologic interventions (e.g., guanfacine), neuromodulation techniques (e.g., repetitive transcranial magnetic stimulation [TMS]), and therapies involving altered states of consciousness (i.e., ketamine, MDMA, psilocybin, and anesthesia-induced dreaming). Across these modalities, Dr. Hack's focus is on tailoring treatment based on objective, biologically anchored markers that match the patient’s profile.

    Dr. Hack also directs the Stanford Precision Psychiatry Clinic, a high-touch, high-tech consultation service designed to support individuals with a primary diagnosis of major depression and often comorbid MATRDs. This clinic integrates the investigational use of high-definition neuroimaging (personalized brain circuit scores) with symptom profiling, neurocognitive testing, pharmacogenomic analysis, inflammatory biomarkers, and standard blood work. The aim is to generate individualized insights that inform treatment decisions and help patients better understand the biological underpinnings of their condition—often reducing self-blame and empowering engagement in care.

    In her role as Deputy Director as well as Ketamine and Education Lead of the Precision Neuromodulation Clinic (PNC) at PAVAHCS, Dr. Hack specializes in delivering evidence-based, FDA-cleared interventions including TMS and intranasal ketamine for Veterans experiencing treatment-resistant depression, frequently in the context of comorbid PTSD.

  • Haijing Wu Hallenbeck

    Haijing Wu Hallenbeck

    Instructor (Affiliated), Psych/Public Mental Health & Population Sciences
    Staff, Psych/Public Mental Health & Population Sciences

    BioHaijing Hallenbeck, PhD, is a research investigator at the National Center for PTSD Dissemination & Training Division at VA Palo Alto Health Care System. She is also an Instructor (Affiliated) in the Department of Psychiatry and Behavioral Sciences at Stanford University School of Medicine. She received her PhD in Clinical Psychology from Washington University in St. Louis and completed her predoctoral clinical internship and postdoctoral research fellowship at VA Palo Alto Health Care System. Funded by VA Career Development Awards, Dr. Hallenbeck's research focuses on PTSD and depression and their impact on psychosocial functioning. She studies how to leverage digital health technology (e.g., mobile apps) and analytic tools (e.g., network analysis) to provide timely and personalized assessments and interventions.

    Email: haijing.hallenbeck@stanford.edu

  • Kate Hardy

    Kate Hardy

    Clinical Professor, Psychiatry and Behavioral Sciences

    BioKate Hardy is a California Licensed Psychologist who has specialized in working with individuals with psychosis for over 20 years in both research and clinical settings. Dr. Hardy received her doctorate in clinical psychology from the University of Liverpool, United Kingdom. She has worked in specialist early psychosis services in both the UK and the US, including UCSF’s Prodrome Assessment Research and Treatment (PART) program, where she completed her post-doctoral fellowship, and as Clinical Director for the Prevention and Recovery from Early Psychosis (PREP) program. Dr. Hardy is the co-director for the INSPIRE clinic at the Department of Psychiatry and Behavioral Health, Stanford University and has significant experience in providing CBTp to individuals with early psychosis, and those at risk of developing psychosis, in both individual and group settings and integration of this clinical intervention to broader systems and staff teams. Dr. Hardy is also involved in the implementation of national strategies to increase dissemination of early psychosis models with the aim of bringing these cutting edge treatments to a broader population and is the co-editor of the book Intervening Early: A team approach.

    Dr. Hardy is also the director of INSPIRE training and within this role has led multiple trainings and workshops in CBTp to a wide variety of audiences including community clinicians, psychiatrists, and families, and provides ongoing supervision and consultation in this approach. INSPIRE training offers training in evidence based interventions for psychosis to providers across diverse settings. In 2024 Dr. Hardy became president elect for IEPA: Intervening Early in Mental Health.

  • Alesha Heath

    Alesha Heath

    Basic Life Research Scientist, Psych/Public Mental Health & Population Sciences

    BioDr. Alesha Heath is a Postdoctoral Scholar at Psychiatry and Behavioral Sciences at Stanford School of Medicine and the MIRECC the VA Palo Alto. She earned her PhD from the University of Western Australia and Sorbonne University.

    Dr. Heath's research has been primarily focused on the mechanisms and applications of brain stimulation therapies, in particular repetitive transcranial magnetic stimulation. Her research involves both basic and clinical components with the aim of improving the efficacy of these therapies for the treatment of disorders such as depression and Alzheimer's disease.

  • Nuriya Ruth Hefron

    Nuriya Ruth Hefron

    Professional - NX, Psych/Public Mental Health & Population Sciences

    Current Role at StanfordProgram Manager INSPIRE 360
    Expansion of Early Psychosis Care Program

  • Charlie Heriot-Maitland

    Charlie Heriot-Maitland

    Adjunct Lecturer, Psych/Public Mental Health & Population Sciences

    BioDr Heriot-Maitland is a clinical psychologist, trainer, researcher, and author. He is an international expert in Compassion Focused Therapy (CFT), and specifically the application of CFT for voice-hearing, trauma, and for people with psychosis and complex needs. Dr Heriot-Maitland is an experienced CFT therapist himself, and for the last 10 years has been leading the international development, research, and training of CFT for psychosis. His clinical research in this area has been mainly carried out at King’s College London and University of Glasgow, supported by funding from the UK Medical Research Council.

    Dr Heriot-Maitland has published extensively on the theory and application of CFT in academic journals, produced videos and training materials, and has co-authored a self-help book on CFT for voice-hearers (Routledge, 2022). He has also developed novel and innovative interventions, based on CFT, for applications in different sectors (e.g., healthcare, social care, and education). Since 2012, he has been co-director of a UK organisation, Balanced Minds, which specialises in providing CFT therapy and resources for the general public and CFT training and supervision for professionals. He has been delivering training sessions at Stanford since 2019, and has held an Adjunct Lecturer appointment with the university since 2022.

  • Keith Humphreys

    Keith Humphreys

    Esther Ting Memorial Professor and Professor, by courtesy, of Health Policy

    Current Research and Scholarly InterestsDr. Humphreys researches individual and societal level interventions for addictive and psychiatric disorders. He focuses particularly on evaluating the outcomes of professionally-administered treatments and peer-operated self-help groups (e.g., Alcoholics Anonymous), and, analyzing the impact of public policies touching addiction, mental health, public health, and public safety.

  • Alison Hwong

    Alison Hwong

    Assistant Professor of Psychiatry and Behavioral Sciences (Public Mental Health and Population Sciences)

    BioMy research focuses on improving health outcomes for people with mental illness, including: physical health and premature mortality for people with serious mental illness, aging and living with psychosis, social determinants of mental health, and the mental health effects of climate change.

  • Gabriella Imbriano

    Gabriella Imbriano

    Clinical Assistant Professor, Psychiatry and Behavioral Sciences

    BioGabriella Imbriano, Ph.D. is the Co-Director for the Center for Mental Health Implementation Support (CMHIS) within the Stanford Center for Dissemination and Implementation and is a Clinical Assistant Professor within the Stanford School of Medicine. Dr. Imbriano is a clinical psychologist and research scientist. She is passionate about increasing access to evidenced-based mental health interventions and her previous work in the Veterans Health Administration, and in various university and academic medical centers, has inspired her commitment to science and practice integration. She has clinical expertise and research interests in traumatic stress disorders and trauma-informed care, women’s health care, and their intersections with implementation science.

  • Shaili Jain, MD

    Shaili Jain, MD

    Adjunct Clinical Professor, Psychiatry and Behavioral Sciences

    BioDr. Jain is a board certified psychiatrist with specialty expertise in posttraumatic stress disorder (PTSD), primary and mental health integrated care, and women’s health psychiatry. She is a former health services researcher, affiliated with the National Center for PTSD, who focuses on developing innovative ways to enhance the reach of mental healthcare in underserved populations with PTSD. Her work is widely accredited for elucidating the role of paraprofessionals and peers in the treatment of American veterans with PTSD.

    She serves as the Psychiatry representative on Stanford's Executive Committee of the Association of Adjunct Clinical Faculty (AACF) and is also a council member for the Adjunct Clinical Faculty (ACF) council in Stanford's department of psychiatry. She is a distinguished fellow of the American Psychiatric Association.

    Dr. Jain is an internationally recognized leader in communicating to the public about trauma and PTSD. Her posts for her Psychology Today blog on PTSD, In the Aftermath of Trauma, have been viewed over 350,000 times. Her acclaimed debut non-fiction trade book, The Unspeakable Mind: Stories of Trauma and Healing from the Frontlines of PTSD Science (Harper, 2019), was nominated for a National Book Award, and her essays and commentaries on trauma and PTSD have been presented by the BBC, CNN, The New York Times, STAT, Newsweek, The Los Angeles Times, The Washington Post, The Atlantic, USA Today, TEDx, public radio, and others

  • Debra Lee Kaysen

    Debra Lee Kaysen

    Professor of Psychiatry and Behavioral Sciences (Public Mental Health and Population Sciences)

    Current Research and Scholarly InterestsMuch of my current research focus is on the development of testing of accessible, scaleable, and effective treatments for trauma-related disorders and related comorbidities (e.g. substance use disorders, HIV, mood disorders). This work has focused on addressing trauma-related disorders especially in underserved populations and settings. This includes research in rural communities, with Native American communities, and with sexual minorities. My research has had a strong impact on building an evidence base on adaptations of psychotherapies for PTSD and substance use disorders for diverse populations both within and outside the United States. Our findings demonstrate that complex cognitive behavioral psychotherapies like Cognitive Processing Therapy can be culturally adapted and delivered in challenging settings (conflict settings, high poverty environments) with significant and lasting change in PTSD, depression, and functioning. This has led to work adapting CPT for diverse populations within the United States (rural Native Americans, urban Latinos) and outside of it (Iraq, DRC). Other research has focused on treatment for PTSD/SUD. My research has also found support for the use of brief telehealth interventions to build treatment engagement and to reduce drinking among trauma-exposed populations. In addition, my work has been critical in testing the feasibility of novel trauma-focused interventions for use by those with PTSD and SUD, thus paving the road for more rigorous research studies.

    Current PI'ed research studies include: 1) developing and evaluating a brief motivational interviewing intervention designed to increase treatment-seeking among military personnel with untreated PTSD; a two-arm randomized comparative effectiveness trial to evaluate prevention of HIV/STI sexual risk behavior by addressing PTSD through Narrative Exposure Therapy or substance use through Motivational Interviewing among Native American men and women with PTSD; and 3) a comparison of outcomes among patients randomized to initially receive pharmacotherapy or Written Exposure Therapy delivered in primary care as well as comparing outcomes among patients randomized to treatment sequences (i.e., switching and augmenting) for patients who do not respond to the initial treatment.

  • Corey Keller, MD, PhD

    Corey Keller, MD, PhD

    Associate Professor of Psychiatry and Behavioral Sciences (Public Mental Health and Population Sciences)

    Current Research and Scholarly InterestsThe goal of my lab is to understand the fundamental principles of human brain plasticity and build trans-diagnostic real-time monitoring platforms for personalized neurotherapeutics.

    We use an array of neuroscience methods to better understand the basic principles of how to create change in brain circuits. We use this knowledge to develop more effective treatment strategies for depression and other psychiatric disorders.

  • Christina Khan, MD, PhD

    Christina Khan, MD, PhD

    Clinical Professor, Psychiatry and Behavioral Sciences

    BioDr. Christina Khan is a pediatric and adult psychiatrist and Clinical Professor in the Department of Psychiatry and Behavioral Sciences. She specializes in the treatment of trauma, depression, anxiety, LGBTQ+ health, and physician wellness. Dr. Khan’s training includes doctoral and postdoctoral research training in community and public health, including specialized training in global health and PTSD research and treatment. Her work focuses on addressing health disparities in underserved populations and treating vulnerable and marginalized populations here in the United States and abroad.

    At Stanford, she is co-Chief of the Diversity and Cultural Mental Health Section in the Department of Psychiatry and Behavioral Sciences and founder and Director of THRIVE, Stanford's LGBTQ+ mental health clinic. She has been working with WellConnect since 2014 addressing burnout, trauma, and secondary trauma in Stanford physicians. Dr. Khan is also a Faculty Fellow at the Center for Innovation in Global Health (CIGH) and serves on the CIGH Program Leadership Committee.

    Nationally, Dr. Khan serves as Past President of the Association of Women Psychiatrists and as Councilor for the Council on Minority Mental Health and Health Disparities of the American Psychiatric Association.

  • Jane P. Kim

    Jane P. Kim

    Clinical Associate Professor, Psychiatry and Behavioral Sciences

    Current Research and Scholarly InterestsDr. Kim’s research focuses on applying statistical approaches to evaluate and improve digital interventions, and using empirical approaches to understand ethical considerations for AI applications in healthcare.

  • Feng Vankee Lin

    Feng Vankee Lin

    Associate Professor of Psychiatry and Behavioral Sciences (Public Mental Health & Population Sciences)

    Current Research and Scholarly InterestsMy career has been devoted to understanding the neural mechanisms involved in brain aging and brain plasticity, with a special focus on early detection and prevention of Alzheimer’s disease (AD). My research approach integrates principles and findings from cognitive theory, clinical neuroscience, and computational neuroscience.

  • Steven Lindley

    Steven Lindley

    Professor of Psychiatry and Behavioral Sciences (Public Mental Health and Population Sciences)

    Current Research and Scholarly InterestsMaximizing the use of evidence-based practices and reducing unnecessary medical burden of psychiatric treatments for stress-related disorders.

  • Michelle Madore, Ph.D.

    Michelle Madore, Ph.D.

    Clinical Associate Professor (Affiliated), Psych/Public Mental Health & Population Sciences
    Staff, Psych/Public Mental Health & Population Sciences

    BioDr. Madore is multiracial, Filipina woman working as a Clinical Neuropsychologist at VA Palo Alto Healthcare System (VAPAHCS) in the Mental Illness Research, Education and Clinical Center (MIRECC).  Here she serves as the Director of the National Clinical Transcranial Magnetic Stimulation (TMS) Program whose mission is to: 1) increase the availability of Transcranial Magnetic Stimulation (TMS) for treatment-resistant depression in Veterans and (2) gain a greater understanding of the treatment efficacy of TMS in our complex Veteran population. She is also the Co-Director of the Sierra Pacific MIRECC Advanced Fellowship at VAPAHCS. Dr. Madore is the Co-PI for studies looking at the clinical efficacy and safety for substance use disorders, specifically methamphetamine and alcohol. Dr. Madore is also a Clinical Associate Professor (Affiliated) at Stanford University School of Medicine’s Department in Psychiatry and Behavioral Sciences.

    She received her Ph.D. in clinical psychology from the University of Cincinnati, where she received specialized training in neuropsychology. Dr. Madore completed her pre-doctoral internship at the VA Palo Alto Health Care System (VAPAHCS).  She has completed postdoctoral training focused on clinical neuropsychology and neurorehabilitation research at VA Martinez, San Francisco VA Medical Center and VAPAHCS.

    Dr. Madore is involved in several professional organizations and serves in several leadership positions. She is the Editor for the Asian American Journal of Psychology and Deputy Editor for Transcranial Magnetic Stimulation.

  • Peter Manoleas

    Peter Manoleas

    Adjunct Clinical Instructor, Psychiatry and Behavioral Sciences

    BioPeter Manoleas is a Licensed Clinical Social Worker with over 40 years’ experience in mental health and substance abuse as a clinician, administrator, and educator. He is emeritus faculty at the UC Berkeley, School of Social Welfare, having retired from the full time faculty in 2012. Manoleas has consulted widely, including to the (former) California Department of Mental Health, the (former) Mental Health Services Act Oversight and Accountability Commission, The California Endowment, and the UCSF Department of Psychiatry. He is the 2012 recipient of the California Wellness Foundation’s “Champion of Health Professions Diversity” award. He is on the editorial board of the Journal of Social Work Practice in the Addictions as well as a regular reviewer for Psychiatric Services, Manoleas has served on numerous boards and commissions, including the California Board of Behavioral Sciences on which he served from 2002-2006, the last year as Chair. He currently maintains a part-time practice.

  • Ryan Matlow

    Ryan Matlow

    Clinical Associate Professor, Psychiatry and Behavioral Sciences

    BioRyan Matlow, Ph.D., is a child clinical psychologist who serves as Director of Community Programs for Stanford’s Early Life Stress and Resilience Program, and is a faculty member in Stanford's Human Rights and Trauma Mental Health Program. His clinical and research efforts focus on understanding and addressing the impact of stress, adversity, and trauma in children, families, and communities. In particular, Dr. Matlow seeks to apply current scientific knowledge of the neurobiological and developmental impact of stress, trauma, and adversity in shaping interventions and systems of care. Dr. Matlow is focused on engaging diverse populations and providing evidence-based individual, family, and systems interventions for posttraumatic stress following interpersonal trauma, with an emphasis on efforts in school, community, and integrated care settings. He is engaged in clinical service, program development, and interdisciplinary collaboration efforts that address childhood trauma exposure in communities that have been historically marginalized, under-resourced, and/or experienced human rights violations. He has worked extensively in providing trauma-focused psychological evaluation, treatment, and advocacy services with immigrant youth and families, with a focus on immigrants from Latin American countries. Dr. Matlow is involved in the training and dissemination of Stanford's Cue Centered Therapy (Carrion, 2015), a flexible, manualized intervention addressing childhood experiences of chronic trauma.

  • Mark McGovern

    Mark McGovern

    Professor of Psychiatry and Behavioral Sciences (Public Mental Health and Population Sciences) and, by courtesy, of Pediatrics

    BioDr. Mark McGovern is a Professor and the Associate Chair of Translation and Implementation Research in the Department of Psychiatry & Behavioral Sciences and, by courtesy, the Department of Medicine at Stanford University School of Medicine.

    Most people who need health care do not receive it. And of those who do, wide variation exists in access to care and the quality of the care they receive in health care systems, both private and public. Dr. McGovern is a leader in using rigorous methods of implementation science to close these gaps in health care delivery.

    His mission is to get the best health care possible to the people who need it the most.

    Dr. McGovern's primary focus is the implementation and sustainment of evidence-based interventions and guideline adherent care in public and private health care systems and organizations. Within the hub of the Stanford Center for Dissemination and Implementation (CDI) which he directs, Dr. McGovern is the Principal Investigator (PI) and leads three national implementation research and practice centers: The Center for Dissemination and Implementation At Stanford (C-DIAS); The Research Adoption Support Center (RASC); and, the Mental Health Technology Transfer Center Network Coordinating Center (MHTTC). The 3 centers are federally-funded, respectively by the National Institute on Drug Abuse (P50DA05402), the National Institutes of Health Healing Addiction Long Term (HEAL) initiative (U2CDA057717), and the US Department of Health and Human Services Substance Use and Mental Health Services Administration (H79SM081726). Dr. McGovern is also the PI on a multi-site adaptive implementation trial across a state system of care, which aims to integrate addiction medications for persons with opioid use disorder who are receiving services in specialty or primary care organizations (R01DA052975). In addition, he addresses implementation challenges in federally-qualified health centers (FQHCs) across the State of California, in the Stanford Division of Primary Care and Population Health, and in specialty addiction and mental health treatment organizations nationwide. He leads, facilitates and/or actively engages networks advancing implementation science in health, including the NIDA Clinical Trials Network Translation & Implementation Special Interest Group, the NIDA Clinical Trials Western States Node Translation & Implementation Workgroup, the Stanford University Network for Dissemination & Implementation Research (SUNDIR), the VA Palo Alto HSR&D Center for Innovation to Implementation, and the Stanford Medicine Center for Improvement. He is on the Core Faculty of the National Institute of Mental Health Implementation Research Institute at the Washington University in St. Louis. Dr. McGovern is a collaborator on multiple projects as a co-investigator, consultant, or advisory board member. He is a mentor to numerous individuals across the country and at Stanford, from university undergraduates to mid-career faculty and clinical administrators at academic institutions and health care systems nationwide.

  • Martin Stefan Mumenthaler

    Martin Stefan Mumenthaler

    Adjunct Professor, Psych/Public Mental Health & Population Sciences

    BioMartin Mumenthaler has a PharmD and a PhD in psychopharmacology from the University of Bern, Switzerland. He holds an appointment as Adjunct Professor in the Department of Psychiatry and Behavioral Sciences at Stanford University School of Medicine where he has been conducting research programs in addiction medicine and psychopharmacology, and teaching and mentoring medical students and residents on a voluntary basis.
    Dr. Mumenthaler has also been working in various full-time positions in the pharmaceutical industry as Director in Clinical Development as well as in Medical Affairs, and as a consultant for early-stage pharma- and biotech companies providing advice on designing and conducting clinical trials, and analyzing and interpreting study results, mainly in the field of addiction medicine and pain.
    His academic research has focused on the effects of psychoactive drugs on human performance, Aerospace Medicine, Alzheimer’s disease, and addiction medicine, and in these areas he has presented his results internationally and published over twenty-five peer-reviewed scientific articles. He has also served as a reviewer for various scientific journals, and is a member of the Research Society on Alcoholism, and an Associate Fellow of the Aerospace Medical Association.

  • Kalpana Isabel Nathan

    Kalpana Isabel Nathan

    Adjunct Clinical Professor, Psychiatry and Behavioral Sciences

    BioKalpana Nathan, MD is an adjunct clinical professor, Psychiatry and Behavioral Sciences at the Stanford University School of Medicine. After completion of residency and research fellowship at Stanford, she served 4 years at the San Francisco General Hospital/UCSF, gaining experience in the areas of substance use, HIV and public health. She worked at Palo Alto VA for more than a couple of decades. She served as chief medical director at Mental Health and Addiction services, El Camino Health for two and a half years, and later was the Executive Medical Director of Custody Behavioral Health at Santa Clara County. She is a certified physician executive. She has worked and taught in various settings, both inpatient and outpatient, as well as private and public sectors. She is board certified in General, Addiction and Forensic Psychiatry, as well as Lifestyle Medicine. Her interests include wellness and self-care for physicians, women's health, health creation and resiliency building for the community. She is a certified meditation teacher, has completed sprint and Olympic triathlons, and enjoys traveling around the world. She received the outstanding community clerkship preceptor award in 2010 and the Arthur L. Bloomfield Award in Recognition of Excellence in the Teaching of Clinical Medicine in 2015 at the Stanford University School of Medicine.

    Recent Publications:
    1. Yen Li, M, Mata C, Nathan K: Is Life Unlivable for Youth in Post-DEI America?: Understanding Rising Suicide Rates Across Diverse Youth Groups Through Traditional Suicide Paradigms. Healthcare 2025 Oct, 13(20), 2585 https://doi.org/10.3390/healthcare13202585

    2. Tran BX, Nguyen TT, Boyer L, Fond G, Auquier P, Nguyen HSI,Ha Thi Nhi Tran HTN, Nguyen HM, Choi J, Le HT, Latkin CA, Nathan KI, Husain SF, et al: Differentiating people with schizophrenia from healthy controls in a developing country: An evaluation of portable functional near infrared spectroscopy (fNIRS) as an adjunct diagnostic tool. Frontiers of Psychiatry 2023 Jan 26; vol 14

    3. Tatum, J, Nathan, K: The USA. Lancet Psychiatry 2021, 8(5):365-366

    4. Nathan N & Nathan KI: Suicide, Stigma, and Utilizing Social Media Platforms to Gauge Public Perceptions. Front. Psychiatry 2020 January 13

    5. Tran BX, Nathan KI, Phan HT, Hall BJ, Vu GT et al: A Global Bibliometric Analysis of Services for Children Affected by HIV/Acquired Immune Deficiency Syndrome: Implications for Impact Mitigation Programs (GAPRESEARCH). AIDS Rev. 2019 Oct 3;21(3).

    6.Lee A, Nathan KI: Understanding Psychosis in a Veteran With a History of Combat and Multiple Sclerosis. Fed Pract. 2019 Jun;36(Suppl 4):S32-S35.

    7. Tran BX, Ha GH, Vu GT, Nguyen LH, Latkin CA, Nathan K, McIntyre RS, Ho CS, Tam WW, Ho RC: Indices of Change, Expectations, and Popularity of Biological Treatments for Major Depressive Disorder between 1988 and 2017: A Scientometric Analysis. Int J Environ Res Public Health. 2019 Jun 26;16(13)

  • Ruth O'Hara

    Ruth O'Hara

    Director, Spectrum, Senior Associate Dean, Research and Lowell W. and Josephine Q. Berry Professor

    Current Research and Scholarly InterestsDr. O'Hara's research aims to investigate how cognitive information processing deficits subserve affective symptoms in psychiatric disorders, and interact with key brain networks integral to these disorders. To do so, she has implemented a translational, interdisciplinary program that encompasses cellular models, brain and behavioral assays of affective and cognitive information processing systems in psychiatric disorders across the lifespan.

  • Karen Osilla

    Karen Osilla

    Professor of Psychiatry and Behavioral Sciences (Public Mental Health and Population Sciences)

    Current Research and Scholarly InterestsDr. Osilla conducts health services research with a focus on supporting families impacted by substance use. Dr. Osilla has been conducting addictions research since 2006 and has been involved in clinical trials evaluating cognitive behavioral therapy, collaborative care, and motivational interviewing interventions (web and in-person) among youth, adult, military, family members, and other hard-to-reach populations.

  • Michael Ostacher

    Michael Ostacher

    Professor of Psychiatry and Behavioral Sciences (Public Mental Health and Population Sciences)

    BioDr. Ostacher is Professor of Psychiatry and Behavioral Sciences. He is the Site Director for the Addiction Medicine Fellowship at the VA Palo Alto Health Care System, where he also serves as the Medical Director of the Pharmacology of Addiction Recovery Clinic, the Director of the Bipolar and Depression Research Program and the Co-Director of the VA/Stanford Exploratory Therapeutics Lab, the Director of Advanced Fellowship Training in Mental Illness Research and Treatment for MDs for the VISN 21 MIRECC, and the Site Director at the VA Palo Alto for Advanced Fellowship Training for Stanford. A graduate of Vanderbilt University School of Medicine, the Harvard School of Public Health, and Harvard Medical School, he completed his training at The Cambridge Health Alliance at Harvard Medical School in Adult Psychiatry, Public Psychiatry, and Geriatric Psychiatry, and is currently board certified in Psychiatry, Addiction Psychiatry, and Addiction Medicine. He is the Digital Content Editor for the journal Evidence-Based Mental Health and is on the editorial boards of Bipolar Disorders, the International Journal of Bipolar Disorders, the Journal of Clinical Psychiatry, Current Psychiatry, and Psychiatric Annals. His current research includes roles as Site Investigator for VA-BRAVE, multicenter, randomized trial comparing long-acting injectable buprenorphine to sublingual buprenorphine/naloxone, and trials of psychedelic drugs in psychiatric disorders in Veterans. With funding from NIDA, he studied, along with Jaimee Heffner, Ph.D. at the Fred Hutchinson Cancer Research Center in Seattle, smoking cessation in people with bipolar disorder using a novel online psychotherapy derived from Acceptance and Commitment Therapy. His work using a Capnometry Guided Respiratory Intervention (CGRI) for PTSD led to the FDA clearance for Freespira, a digital therapeutic, for the treatment of PTSD. His primary research interest is in large clinical trials mental health and addiction, and the implementation of evidence-based mental health practices.

  • Ankita Patil

    Ankita Patil

    Research Assistant, Psych/Public Mental Health & Population Sciences

    BioAnkita Patil is a public health researcher focused on advancing health equity through a social justice–centered framework. She holds a B.A. in Social Psychology from The College of New Jersey and an M.S. in Community Health and Prevention Research from Stanford University. Her research experience includes work at Brigham and Women’s Hospital and Johns Hopkins University, where she examined the health impacts of incarceration, trauma-informed care, and reproductive health among incarcerated populations. Ankita is a co-author of an American Public Health Association policy statement calling for an end to shackling incarcerated patients and has peer-reviewed work on COVID-19 in Massachusetts prisons. Her work bridges research, policy, and community-based advocacy to advance humane public health solutions.